Management of postoperative recurrence of Crohn's disease

Digestive Diseases

Volumn 31, Issue 2, 2013, Pages 222-228

  Van Lent, Anja U ^a   D'haens, Geert R ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Crohn's disease; Postoperative recurrence; Surgery; Treatment

Indexed keywords

ADALIMUMAB; AMINOSALICYLIC ACID; AZATHIOPRINE; IMIDAZOLE; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; ORNIDAZOLE; 6 MERCAPTOPURINE DERIVATIVE; PLACEBO;

ANTIBIOTIC THERAPY; ARTICLE; COLONOSCOPY; CROHN DISEASE; DRUG EFFICACY; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT DISEASE; SMOKING; INTESTINE RESECTION; META ANALYSIS (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR;

COLONOSCOPY; CROHN DISEASE; HUMANS; INFLAMMATION; POSTOPERATIVE CARE; RECURRENCE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84884216502     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000353374     Document Type: Article

References (38)

1. Cerqueira RM, Lago PM: Clinical factors predictive of Crohn's disease complications and surgery. Eur J Gastroenterol Hepatol 2013; 25: 129-134.
2. Bernell O, Lapidus A, Hellers G: Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease. Br J Surg 2000; 87: 1697-1701.
3. Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G: Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut 1984; 25: 665-672.
4. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M: Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990; 99: 956-963.
5. Olaison G, Smedh K, Sjodahl R: Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms. Gut 1992; 33: 331-335.
6. Buisson A, Chevaux JB, Allen PB, Bommelaer G, Peyrin-Biroulet L: Review article: the natural history of postoperative Crohn's disease recurrence. Aliment Pharmacol Ther 2012; 35: 625-633.
7. McLeod RS, Wolff BG, Steinhart AH, et al: Risk and significance of endoscopic/radiological evidence of recurrent Crohn's disease. Gastroenterology 1997; 113: 1823-1827.
8. Viscido A, Corrao G, Taddei G, Caprilli R: 'Crohn's disease activity index' is inaccurate to detect the post-operative recurrence in Crohn's disease. A GISC study. Gruppo Italiano per lo Studio del Colon e del Retto. Ital J Gastroenterol Hepatol 1999; 31: 274-279.
9. Larson DW, Pemberton JH: Current concepts and controversies in surgery for IBD. Gastroenterology 2004; 126: 1611-1619.
10. Rutgeerts P, Hiele M, Geboes K, et al: Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995; 108: 1617-1621.
11. D'Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P: Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998; 114: 262-267.
12. Van AG, Dignass A, Reinisch W, et al: The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. J Crohns Colitis 2010; 4: 63-101.
13. Doherty G, Bennett G, Patil S, Cheifetz A, Moss AC: Interventions for prevention of post-operative recurrence of Crohn's disease. Cochrane Database Syst Rev 2009;CD006873.
14. Reinisch W, Angelberger S, Petritsch W, et al: Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial. Gut 2010; 59: 752-759.
15. D'Haens GR, Vermeire S, Van AG, et al: Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial. Gastroenterology 2008; 135: 1123-1129.
16. Regueiro M: Management and prevention of postoperative Crohn's disease. Inflamm Bowel Dis 2009; 15: 1583-1590.
17. van Loo ES, Dijkstra G, Ploeg RJ, Nieuwenhuijs VB: Prevention of postoperative recurrence of Crohn's disease. J Crohns Colitis 2012; 6: 637-646.
18. Buisson A, Chevaux JB, Bommelaer G, Peyrin-Biroulet L: Diagnosis, prevention and treatment of postoperative Crohn's disease recurrence. Dig Liver Dis 2012; 44: 453-460.
19. Moss AC: Prevention of postoperative recurrence of Crohn's disease: what does the evidence support? Inflamm Bowel Dis 2013; 19: 856-859.
20. De Cruz P, Kamm MA, Prideaux L, Allen PB, Desmond PV: Postoperative recurrent luminal Crohn's disease: a systematic review. Inflamm Bowel Dis 2012; 18: 758-777.
21. Greenstein AJ, Lachman P, Sachar DB, et al: Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut 1988; 29: 588-592.
22. Sachar DB, Wolfson DM, Greenstein AJ, Goldberg J, Styczynski R, Janowitz HD: Risk factors for postoperative recurrence of Crohn's disease. Gastroenterology 1983; 85: 917-921.
23. Ahmed T, Rieder F, Fiocchi C, Achkar JP: Pathogenesis of postoperative recurrence in Crohn's disease. Gut 2011; 60: 553-562.
24. Cabre E, Domenech E: Impact of environmental and dietary factors on the course of inflammatory bowel disease. World J Gastroenterol 2012; 18: 3814-3822.
25. Peyrin-Biroulet L, Deltenre P, Ardizzone S, et al: Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis. Am J Gastroenterol 2009; 104: 2089-2096.
26. Ford AC, Sandborn WJ, Khan KJ, Hanauer SB, Talley NJ, Moayyedi P: Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol 2011; 106: 644-659, quiz.
27. Sorrentino D, Terrosu G, Avellini C, Beltrami CA, Bresadola V, Toso F: Prevention of postoperative recurrence of Crohn's disease by infliximab. Eur J Gastroenterol Hepatol 2006; 18: 457-459.
28. Regueiro M, Schraut WH, Baidoo L, et al: Two year postoperative follow-up of patients enrolled in the randomized controlled trial (RCT) of infliximab (IFX) for prevention of recurrent Crohn's disease (CD) (abstract T1207). Gastroenterology 2009; 136:A-522.
29. Regueiro M, Kip KE, Schraut WH, et al: 4.5 yr follow-up of patients enrolled in the randomized controlled trial (RCT) of infliximab (Inf) for prevention of postoperative Crohn's disease (CD) (abstract W1298). Gastroenterology 2010; 138:S-694.
30. Sorrentino D, Paviotti A, Terrosu G, Avellini C, Geraci M, Zarifi D: Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's disease. Clin Gastroenterol Hepatol 2010; 8: 591-599.
31. Aguas M, Bastida G, Cerrillo E, et al: Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients. World J Gastroenterol 2012; 18: 4391-4398.
32. Ferníndez-Blanco I, Monturiol J, Martinez B, Cara C, Taxonera C: Adalimumab in the prevention of postoperative recurrence of Crohn's disease (abstract W1291). Gastroenterology 2010; 138:S-692.
33. Papamichael K, Archavlis E, Lariou C, Mantzaris GJ: Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study. J Crohns Colitis 2012; 6: 924-931.
34. D'Haens GR: Top-down therapy for IBD: rationale and requisite evidence. Nat Rev Gastroenterol Hepatol 2010; 7: 86-92.
35. De Cruz P, Kamm MA, Hamilton AL, et al: Clinical risk stratification predicts development of endoscopic recurrence after Crohn's disease surgery: early results from the POCER study (abstract Su2092). Gastroenterology 2012; 142:S-568.
36. De Cruz P, Kamm MA, Hamilton AL, et al: Adalimumab prevents post-operative Crohn's disease recurrence, and is superior to thiopurines: early results from the POCER study (abstract 1161). Gastroenterology 2012; 142:S-212.
37. De Cruz P, Kamm MA, Hamilton AL, et al: Optimising post-operative Crohn's disease management: best drug therapy alone versus colonoscopic monitoring with treatment step-up. The POCER study (abstract 925j). Gastroenterology 2013; 144:S-164.
38. Baudry C, Pacault V, Simon M, et al: Prevention of postoperative clinical recurrence in Crohn's disease (CD) based on colonoscopy within the first year after surgery for decision of a tailored treatment (abstract P102). J Crohns Colitis 2009; 3:S51.